DBS Bank analyst Nico Chen upgraded Novo Nordisk (NVO) to Hold from Sell with a DKK 340 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk freezes non-critical hiring, Reuters reports
- Viking Therapeutics drop may be partially ‘sell the news,’ says H.C. Wainwright
- Novo Nordisk Announces Executive Share Transactions Amid Market Confidence
- Eli Lilly, Novo Nordisk up 2% each after Viking obesity pill trial results
- Novo Nordisk price target lowered to $70 from $105 at TD Cowen